SEC Form 4 · accession 0001013606-17-000067
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John D McDermott
Officer — Chief Executive Officer · Director
Period of report
May 19, 2017
Accepted (ET)
May 30, 2017 · 1:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 19, 2017 | P | 25,000 | $4.45 | A | 657,169 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reporting person purchased shares on May 19, 2017. Purchase reported on Form 4 late due to administrative error.
Remarks
Total shares owned includes 2,525 shares purchased through the Company's Employee Stock Purchase Plan on April 30, 2017 and have not previously been disclosed due to immateriality.